Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The company is developing therapeutics that target muscle and the central nervous system to address the root cause of disease, with clinical programs in Duchenne muscular dystrophy and myotonic dystrophy type 1 and preclinical programs in facioscapulohumeral muscular dystrophy, Pompe disease, and multiple DMD mutations. The Clinical Operations Study Lead translates clinical strategies into operational plans and executes studies in line with clinical development plans. The role initiates and leads clinical trials across all phases, oversees CROs and vendors, and partners cross-functionally to align study operations with project priorities, timelines, budgets, and quality requirements. The role ensures study conduct complies with relevant regulations, including ICH GCP guidelines and local requirements, as well as Dyne policies and SOPs. The individual may be responsible for one highly complex study or multiple medium-complexity studies. The role is based in Waltham, Massachusetts, and requires up to 20% travel, including international travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior